Table 3 |
|||
|
Serum 8-iso-PGF2-alpha levels at T0 |
|||
|
Treatment Group Subject Number |
8-iso-PGF2-alpha (pg/mL) |
Control Group Subject Number |
8-iso-PGF2-alpha (pg/mL) |
|
|
|||
|
1 |
1431.2 |
17 |
310.9 |
|
|
|||
|
2 |
323.7* |
18 |
131.9* |
|
|
|||
|
3 |
946.8 |
19 |
1011.5 |
|
|
|||
|
4 |
678.7 |
20 |
22.1* |
|
|
|||
|
5 |
974 |
21 |
1121 |
|
|
|||
|
6 |
772.4 |
23 |
107* |
|
|
|||
|
7 |
770.9 |
24 |
818 |
|
|
|||
|
8 |
330.2* |
25 |
206.4* |
|
|
|||
|
9 |
728.4 |
26 |
1503 |
|
|
|||
|
10 |
965.2 |
27 |
414.5 |
|
|
|||
|
11 |
308.9* |
28 |
356.4 |
|
|
|||
|
12 |
756.9 |
29 |
373.4 |
|
|
|||
|
13 |
1432.8 |
30 |
11901 |
|
|
|||
|
14 |
255.2* |
31 |
344.5 |
|
|
|||
|
15 |
582.2* |
32 |
294 |
|
|
|||
|
16 |
728.4* |
||
|
|
|||
|
1subject data excluded due to hemolysis *subjects excluded from subgroup analysis due to lowest 8-iso-PGF2-alpha levels |
|||
|
Nemzer et al. Nutrition Journal 2011 10:67 doi:10.1186/1475-2891-10-67 |
|||
